The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells
Open accessAbstract
BACKGROUND: Human mesenchymal stem cells (MSCs) have been shown to be involved in the formation and modulation of tumor stroma and in interacting with tumor cells, partly through their secretome. Exosomes are nano-sized intraluminal multi-vesicular bodies secreted by most types of cells and have been found to mediate intercellular communication through the transfer of genetic information via coding and non-coding RNAs to recipient cells. Since exosomes are considered as protective and enriched sources of shuttle microRNAs (miRNAs), we hypothesized that exosomal transfer of miRNAs from MSCs may affect tumor cell behavior, particularly angiogenesis. METHODS: Exosomes derived from MSCs were isolated and characterized by scanning electron microscopy analyses, dynamic light scattering measurements, and Western blotting. Fold changes in miR-100 expression levels were calculated in exosomes and their corresponding donor cells by qRT-PCR. The effects of exosomal transfer of miR-100 from MSCs were assessed by qRT-PCR and Western blotting of the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. The quantification of secreted VEGF protein was determined by enzyme-linked immunosorbent assay. The putative paracrine effects of MSC-derived exosomes on tumor angiogenesis were explored by in vitro angiogenesis assays including endothelial cell proliferation, migration and tube formation assays. RESULTS: We found that MSC-derived exosomes induce a significant and dose-dependent decrease in the expression and secretion of vascular endothelial growth factor (VEGF) through modulating the mTOR/HIF-1α signaling axis in breast cancer-derived cells. We also found that miR-100 is enriched in MSC-derived exosomes and that its transfer to breast cancer-derived cells is associated with the down-regulation of VEGF in a time-dependent manner. The putative role of exosomal miR-100 transfer in regulating VEGF expression was substantiated by the ability of anti-miR-100 to rescue the inhibitory effects of MSC-derived exosomes on the expression of VEGF in breast cancer-derived cells. In addition, we found that down-regulation of VEGF mediated by MSC-derived exosomes can affect the vascular behavior of endothelial cells in vitro. CONCLUSIONS: Overall, our findings suggest that exosomal transfer of miR-100 may be a novel mechanism underlying the paracrine effects of MSC-derived exosomes and may provide a means by which these vesicles can modulate vascular responses within the microenvironment of breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 2×
“transcriptional activation of vascular endothelial growth factor (VEGF), a predominant inducer of both normal and pathophysiological angiogenesis [4], is regulated by the transcription factor hypoxia-inducible factor-1α (HIF-1α) through binding to the hypoxia response element within the VEGF gene promoter [5].”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
(2000) · PubMed · Cited by 1,445
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
Lee, Y., EL Andaloussi, S., & Wood, M. J. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds317 · Cited by 938
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
Baglio, S. R., Rooijers, K., Koppers-Lalic, D., Verweij, F. J., Pérez Lanzón, M., Zini, N., Naaijkens, B., Perut, F., Niessen, H. W. M., Baldini, N., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0116-z · Cited by 765
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
Chen, T. S., Lai, R. C., Lee, M. M., Choo, A. B. H., Lee, C. N., & Lim, S. K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp857 · Cited by 658
Lee, J.-K., Park, S.-R., Jung, B.-K., Jeon, Y.-K., Lee, Y.-S., Kim, M.-K., Kim, Y.-G., Jang, J.-Y., & Kim, C.-W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084256 · Cited by 642
Collino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011803 · Cited by 608
Mesenchymal stem cell exosomes
Lai, R. C., Yeo, R. W. Y., & Lim, S. K. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.001 · Cited by 570
Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., & Marini, F. (2011) · Stem Cells · doi:10.1002/stem.559 · Cited by 562
Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507
Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo
Zhu, W., Huang, L., Li, Y., Zhang, X., Gu, J., Yan, Y., Xu, X., Wang, M., Qian, H., & Xu, W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.002 · Cited by 488
Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S., & Rameshwar, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3426 · Cited by 432
mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3
Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R., & Tee, A. R. (2015) · Oncogene · doi:10.1038/onc.2014.164 · Cited by 391
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., Ashraf, M., Weintraub, N., Ma, G., & Tang, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.015 · Cited by 359
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Bergfeld, S. A., & DeClerck, Y. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9222-7 · Cited by 345
Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus
Del Bufalo, D., Ciuffreda, L., Trisciuoglio, D., Desideri, M., Cognetti, F., Zupi, G., & Milella, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2825 · Cited by 317
The role of lymphangiogenesis and angiogenesis in tumor metastasis
Paduch, R. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0281-9 · Cited by 315
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0019 · Cited by 307
Bernatchez, P. N., Soker, S., & Sirois, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31047 · Cited by 295
Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7
Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802857105 · Cited by 268
Lee, T.-H., Seng, S., Sekine, M., Hinton, C., Fu, Y., Avraham, H. K., & Avraham, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040186 · Cited by 265
Cousin, B., Ravet, E., Poglio, S., De Toni, F., Bertuzzi, M., Lulka, H., Touil, I., André, M., Grolleau, J.-L., Péron, J.-M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006278 · Cited by 255
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Nagaraja, A. K., Creighton, C. J., Yu, Z., Zhu, H., Gunaratne, P. H., Reid, J. G., Olokpa, E., Itamochi, H., Ueno, N. T., Hawkins, S. M., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0295 · Cited by 230
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis
Babashah, S., & Soleimani, M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.02.008 · Cited by 215
Self-citationGrundmann, S., Hans, F. P., Kinniry, S., Heinke, J., Helbing, T., Bluhm, F., Sluijter, J. P. G., Hoefer, I., Pasterkamp, G., Bode, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.000323 · Cited by 198
Wu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., & Hicklin, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21865 · Cited by 192
Fox, S. B., Generali, D. G., & Harris, A. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1796 · Cited by 182
MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing
Jin, Y., Tymen, S. D., Chen, D., Fang, Z. J., Zhao, Y., Dragas, D., Dai, Y., Marucha, P. T., & Zhou, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064434 · Cited by 172
Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells
Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 167
Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., Bosco, R., Ingrao, S., Zavan, B., & Zauli, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011140 · Cited by 154
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
Maj, E., Papiernik, D., & Wietrzyk, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3709 · Cited by 153
Liang, Y., Brekken, R. A., & Hyder, S. M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01221 · Cited by 149
Yan, X., Fu, C., Chen, L., Qin, J., Zeng, Q., Yuan, H., Nan, X., Chen, H., Zhou, J., Lin, Y.-L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1577-0 · Cited by 145
Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1
Sharma, R., Sharma, R., Khaket, T. P., Dutta, C., Chakraborty, B., & Mukherjee, T. K. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0324-x · Cited by 140
Roorda, B. D., ter Elst, A., Kamps, W. A., & de Bont, E. S. J. M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.06.004 · Cited by 133
Chen, D., Sun, Y., Yuan, Y., Han, Z., Zhang, P., Zhang, J., You, M., Teruya‐Feldstein, J., Wang, M., Gupta, S., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004177 · Cited by 132
mTOR inhibitors in the treatment of cancer
Fasolo, A., & Sessa, C. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.11.1717 · Cited by 132
Galiè, M., Konstantinidou, G., Peroni, D., Scambi, I., Marchini, C., Lisi, V., Krampera, M., Magnani, P., Merigo, F., Montani, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210920 · Cited by 130
The therapeutic potential of mTOR inhibitors in breast cancer
Steelman, L. S., Martelli, A. M., Cocco, L., Libra, M., Nicoletti, F., Abrams, S. L., & McCubrey, J. A. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12958 · Cited by 124
Ng, W. L., Yan, D., Zhang, X., Mo, Y., & Wang, Y. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.08.007 · Cited by 123
Gebeshuber, C. A., & Martînez, J. (2012) · Oncogene · doi:10.1038/onc.2012.372 · Cited by 94
Caivano, A., Rocca, F. L., Simeon, V., Girasole, M., Dinarelli, S., Laurenzana, I., Stradis, A. D., Luca, L. D., Trino, S., Traficante, A., et al. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0300-x · Cited by 89
M’hamed, I. F., Privat, M., Ponelle‐Chachuat, F., Penault-Llorca, F. M., Kénani, A., & Bignon, Y. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0239-3 · Cited by 78
Zhang, B., Zhao, R., He, Y., Fu, X., Fu, L., Zhu, Z., Fu, L., & Dong, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6790 · Cited by 78
MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development
Deng, L., Li, S., Bai, S., Chen, J., He, X., Martin-Trevino, R., Chen, S., Li, X., Meng, X., Yu, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3710 · Cited by 65
Petrelli, A., Carollo, R., Cargnelutti, M., Iovino, F., Callari, M., Cimino, D., Todaro, M., Mangiapane, L. R., Giammona, A., Cordova, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2962 · Cited by 44
Rotundo, M. S., Galeano, T., Tassone, P., & Tagliaferri, P. (2016) · Oncotarget · doi:10.18632/oncotarget.7446 · Cited by 18
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
The biology, function, and applications of exosomes in cancer
Liu, J., Ren, L., Li, S., Li, W., Zheng, X., Yang, Y., Fu, W., Yi, J., Wang, J., & Du, G. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.001 · Cited by 561
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Li, C., Ni, Y.-Q., Xu, H., Xiang, Q.-Y., Zhao, Y., Zhan, J.-K., He, J.-Y., Li, S., & Liu, Y.-S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00779-x · Cited by 406
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Weng, Z., Zhang, B., Wu, C., Yu, F., Han, B., Li, B., & Li, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01141-y · Cited by 405
Metadata
- Authors
- Pakravan, K., Babashah, S., Sadeghizadeh, M., Mowla, S. J., Mossahebi-Mohammadi, M., Ataei, F., Dana, N., & Javan, M.
- Venue
- Cellular Oncology
- Published
- 2017-07-24
- Volume
- 40
- Issue
- 5
- Pages
- 457-470
- ISSN
- 1570-5870 (ISSN-L)
- 2211-3428
- 2211-3436
- OpenAlex
- W2737829281
- Cited by
- 346
- References
- 63
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.